← All organizations
Yiling Pharmaceutical Inc.
For profitWebsite ↗
Also known as: BEIJING YILING | Boao Yiling Life Care Center | Conjupro Biotherapeutics | Conjupro Biotherapeutics, Inc. | Conupro Biotehrapeutics, and CSPC | CSPC Ouyi Pharmaceutical Co., Ltd. | Shijiazhuang Yiling Pharmaceutical Co. Ltd | Shijiazhuang Yiling Pharmaceutical company, LTD | YILING | Yiling Pharmaceutical | Yiling Pharmaceutical Inc. | YILING PHARM LTD
Highest phase reached
Phase 4
Timeline
1990s
- Jun 1, 1992
Yiling Pharmaceutical Inc.— Founded
2020s
- Apr 3, 2020
memantine— Marketing Organization
Drugs by trial phase (76 distinct, 87 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (28 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Phase 1 (16 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Asthma
- Biliary Tract Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cognitive Dysfunction
- Diabetes Mellitus, Type 2
- Dyslipidemias
- Epilepsy
- Hypertension
- Influenza, Human
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Parkinson Disease
- Sclerosis
- Stomach Neoplasms
- Triple Negative Breast Neoplasms
- Tuberous Sclerosis
Marketed drugs (17)
Recent trials (50)
- NCT07288814CollaboratorPhase 1/Phase 2Dec 8, 2025
- NCT07162116Lead sponsorPhase 1Jul 6, 2025
- NCT07014540CollaboratorPhase 4Jun 20, 2025
- NCT07026968Lead sponsorPhase 3Jun 20, 2025
- NCT06943950Lead sponsorPhase 3Jun 1, 2025
- NCT06921044CollaboratorPhase 2Apr 16, 2025
- NCT06958692Lead sponsorPhase 3Apr 11, 2025
- NCT06894797CollaboratorN/AApr 1, 2025
- NCT06755944Lead sponsorPhase 2/Phase 3Dec 15, 2024
- NCT06562894Lead sponsorPhase 2Nov 16, 2024
- NCT06823232Lead sponsorPhase 1Nov 6, 2024
- NCT06571461Lead sponsorPhase 3Sep 30, 2024
- NCT06463548CollaboratorN/AJul 1, 2024
- NCT06430827CollaboratorPhase 2Jun 30, 2024
- NCT06451666Lead sponsorPhase 3Jun 30, 2024
Details
- Founded
- Shijiazhuang, CN Jun 1, 1992
- Last known activity
- Dec 8, 2025